ELAN CORP PLC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Cash Flows

In millions of USD, except per-share amounts

	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Cash flows from operating activities:
Net (loss)/income
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:
Amortization of deferred revenue
Amortization of financing costs
Depreciation and amortization
Gain on sale of investment securities
Impairment of property, plant and equipment
Impairment of intangible assets
Impairment of investments
Net loss/(gain) on divestment of business
EDT divestment transaction costs
Net loss on equity method investments
Loss on disposal of equity method investment
Settlement reserve charge
Share-based compensation
(Recognition)/write-down of deferred tax assets
Net charge on debt retirement
Derivative fair value loss/(gain)
Other
Net changes in assets and liabilities:
(Increase)/decrease in accounts receivable
Decrease/(increase) in prepaid and other assets
(Increase)/decrease in inventory
Decrease in debt interest accrual
Increase/(decrease) in accounts payable and accruals and other liabilities
Decrease in working capital from divestment of EDT business
Net cash provided by/(used in) operating activities
Cash flows from investing activities:
Decrease/(increase) in restricted cash
Proceeds from disposal of property, plant and equipment
Purchase of property, plant and equipment
Purchase of intangible assets
Purchase of equity method investment
Purchase of investment securities
Sale of non-current investment securities
Funding of equity method investment in Janssen AI
Sale of investment securities
Receipt of deferred consideration
Proceeds from sale of equity method investment
Proceeds from business disposals
Net cash provided by/(used in) investing activities
Cash flows from financing activities:
Cash distribution to Prothena Corporation, plc
Proceeds from share based compensation stock issuances
Repayment of loans
Net proceeds from debt issuances
Net cash used in financing activities
Effect of exchange rate changes on cash
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental cash flow information:
Interest
Income taxes
Non-cash investing activities:
Purchase of equity method investment
Transfer of assets, net of liabilities to Prothena Corporation, plc (Note 28).

Comments